Penserra Capital Management’s BlackRock Health Sciences Trust II BMEZ Stock Holding History

Penserra Capital Management’s Portfolio BMEZ Stock Details BMEZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$7.13M	Sell	496,422 -972,107	-66%	-$14.4M	0.08%	245
2025 Q4	$22.1M	Buy	1,468,529 +135,896	+10%	+$2.04M	0.26%	111
2025 Q3	$19.2M	Buy	1,332,633 +175,629	+15%	+$2.49M	0.23%	120
2025 Q2	$16.5M	Buy	1,157,004 +34,191	+3%	+$489K	0.23%	145
2025 Q1	$16.7M	Buy	1,122,813 +81,010	+8%	+$1.27M	0.3%	93
2024 Q4	$15M	Buy	1,041,803 +70,187	+7%	+$1.09M	0.27%	89
2024 Q3	$15.4M	Buy	+971,616	New	+$15.3M	0.33%	67

Other funds holding BMEZ

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

RCM

Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.66% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

SCM

Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

1CP

1607 Capital Partners Richmond, Virginia $1.39B AUM 8.35% 1-Year Est. Return

Penserra Capital Management's BMEZ Position: Q1 2026 in Review

Penserra Capital Management reduced its BlackRock Health Sciences Trust II (BMEZ) stake by 66% in Q1 2026, selling an estimated $14.4M and leaving 496,422 shares worth $7.13M. The position accounts for 0.08% of the portfolio, ranked #245.

Penserra Capital Management first reported a position in BMEZ in Q3 2024 and has held it in 7 quarters since. The position peaked at $22.1M in Q4 2025. 88 funds tracked by Wall St. Rank hold BMEZ as of Q1 2026.

Penserra Capital Management held 496,422 shares of BlackRock Health Sciences Trust II worth $7.13M as of Q1 2026.
Penserra Capital Management sold 972,107 BlackRock Health Sciences Trust II shares in Q1 2026, an estimated $14.4M.
BlackRock Health Sciences Trust II made up 0.08% of Penserra Capital Management's portfolio in Q1 2026, its #245 holding.
Penserra Capital Management first reported a position in BlackRock Health Sciences Trust II in Q3 2024 and has held it in 7 quarters since.
Penserra Capital Management's BlackRock Health Sciences Trust II position peaked at $22.1M in Q4 2025.
88 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust II as of Q1 2026.

Based on Penserra Capital Management's 13F filing for Q1 2026, filed 11 May 2026.